Early clinical phenotype of late onset Pompe disease: Lessons learned from newborn screening
- 23 January 2022
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 135 (3) , 179-185
Abstract
No abstract availableKeywords
Funding Information
- Amicus Therapeutics Inc
This publication has 28 references indexed in Scilit:
- Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center studyOrphanet Journal of Rare Diseases, 2012
- Assessing disease severity in Pompe disease: The roles of a urinary glucose tetrasaccharide biomarker and imaging techniquesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2012
- Patients-in-WaitingJournal of Health and Social Behavior, 2010
- Pompe Disease in Infants: Improving the Prognosis by Newborn Screening and Early TreatmentPediatrics, 2009
- Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarkerGenetics in Medicine, 2009
- Cardiac evaluation in children and adults with Pompe disease sharing the common c.−32-13T>G genotype rarely reveals abnormalitiesJournal of the Neurological Sciences, 2008
- Early Detection of Pompe Disease by Newborn Screening Is Feasible: Results From the Taiwan Screening ProgramPediatrics, 2008
- Broad spectrum of Pompe disease in patients with the same c.-32-13T→G haplotypeNeurology, 2007
- Pompe disease diagnosis and management guidelineGenetics in Medicine, 2006
- Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients.Journal of Medical Genetics, 1995